Search results
Results from the WOW.Com Content Network
Pertussis vaccine is a vaccine that protects against whooping cough (pertussis). [ 1 ] [ 2 ] There are two main types: whole-cell vaccines and acellular vaccines. [ 1 ] [ 2 ] The whole-cell vaccine is about 78% effective while the acellular vaccine is 71–85% effective.
Preventable with vaccine and PEP but once symptoms manifest, there is no cure and the CFR is greater than 99%. 4 known people who survived were simply vaccinated too late, [5] after symptoms started; more recently, at least 3 individuals have survived after being placed in a medically induced coma, however this protocol has since been disputed. [6]
Whooping cough (/ ˈ h uː p ɪ ŋ / or / ˈ w uː p ɪ ŋ /), also known as pertussis or the 100-day cough, is a highly contagious, vaccine-preventable bacterial disease. [1] [10] Initial symptoms are usually similar to those of the common cold with a runny nose, fever, and mild cough, but these are followed by two or three months of severe coughing fits. [1]
Whooping cough, aka pertussis, ... CDC data show that there have been 10,865 recorded cases of whooping cough compared with the ... Get up to date on vaccines. When the updated COVID-19 vaccine ...
In the 1990s, the US changed the type of vaccines used to prevent pertussis, moving from a whole-cell vaccine that caused children to spike fevers and experience other worrisome symptoms after ...
The VICP covers all vaccines listed on the Vaccine Injury Table maintained by the Secretary of Health and Human Services; in 2007 the list included vaccines against diphtheria, tetanus, pertussis (whooping cough), measles, mumps, rubella (German measles), polio, hepatitis B, varicella (chicken pox), Haemophilus influenzae type b, rotavirus, and ...
Data published by the Centers for Disease Control and Prevention on Thursday shows there were 291 cases of whooping cough, or pertussis, last week, adding up to 14,569 cases this year compared to ...
The plan, which is set from 2011 to 2020, is intended to "strengthen routine immunization to meet vaccination coverage targets; accelerate control of vaccine-preventable diseases with polio eradication as the first milestone; introduce new and improved vaccines and spur research and development for the next generation of vaccines and technologies."